促红细胞生成素在急性肾功能衰竭患者中的临床应用观察(3)
 |
| 第1页 |
参见附件(2177KB，3页)。
[6]Mitra A, Bansal S, Wang W, et al. Erythropoietin ameliorates renal dysfunction during endotoxaemia [J]. Nephrol Dial Transplant,2007,22(8):2349-2353.
[7]Salahudeen AK, Haider N, Jenkins J, et al. Anti-apoptotic properties of erythropoiesis stimulating proteins in models of cisplatin-induced acute kidney injury [J]. Am J Physiol Renal Physiol,2008,294(6:):F1354-1365. [8]Sharples EJ, Yaqoob M. Erythropoietin in experimental acute renal failure [J]. Nephron Exp Nephrol,2006,104(3):e83-88.
[9]Sharples EJ, Thiemermann C, Yaqoob MM. Mechanisms of disease: cell death in acute renal failure and emerging evidence for a protective role of erythropoietin [J]. Nat Clin Pract Nephrol,2005,1(2):87-97.
[10]Johnson DW, Pat B, Vesey DA, et al. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure [J]. Kidney Int,2006,69(10):1806-1813.
[11]Sturiale A, Campo S, Crascì E. Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect？[J]. Ren Fail,2007,29(3):379-386.
[12]Goldfarb M, Rosenberger C, Ahuva S. A role for erythropoietin in the attenuation of radiocontrast-induced acute renal failure in rats [J]. Ren Fail,2006,28(4):345-350.
[13]Spandou E, Tsouchnikas I, Karkavelas G, et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model [J]. Nephrol Dial Transplant,2006,21(2):330-336.
[14]Park J, Gage BF, Vijayan A. Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy [J]. Am J Kidney Dis,2005,46(5):791-798.
(收稿日期：2009-03-06)
您现在查看是摘要介绍页，详见PDF附件(2177KB，3页)。